EndoGastric Solutions, Inc. ( EndoGastric Solutions)

Primary tabs

EndoGastric Solutions's picture

Management

Contact Address

About EndoGastric Solutions, Inc.

EndoGastric Solutions (EGS) is a medical device company that develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The advantages of natural orifice surgery over laparoscopic or open surgery include shorter hospital stay, reduced patient discomfort, faster patient recovery, no visible scars, and typically higher patient satisfaction.

EndoGastric Solutions press release, blog etc

Mon, 12/05/2022 - 10:42 EndoGastric Solutions, Inc. Announces CEO Transition and $18M Financing to Expand Commercialization
Mon, 08/08/2022 - 21:56 EndoGastric Solutions, Inc. Announces TIF Procedure Included in New American Gastroenterology Association (AGA) Clinical Practice Update and American College of Gastroenterology (ACG) Guideline
Mon, 07/04/2022 - 09:55 EndoGastric Solutions, Inc. Develops Reflux-Friendly Cookbook to Promote GERD Awareness Week
Wed, 06/23/2021 - 01:47 GERDHelp Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support, Provided by EndoGastric Solutions
Fri, 12/06/2019 - 18:08 Interview: Dr. John Pandolfino discusses role of TIF procedure in GERD
Thu, 09/05/2019 - 14:43 EndoGastric Solutions Announces New Data Confirming the Efficacy of Concomitant Hiatal Hernia Repair and TIF 2.0 Procedure in Providing Symptom Control for GERD Patients
Thu, 06/20/2019 - 14:00 DDW 2019 report on TIF procedure data presented
Tue, 05/28/2019 - 14:12 EndoGastric Solutions Closes Series I Financing at a Total of $45 Million
Thu, 05/09/2019 - 05:26 EndoGastric Solutions TIF 2.0 Procedure Highlighted in Multiple Sessions at DDW 2019
Tue, 02/05/2019 - 17:06 EndoGastric Solutions Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients
Mon, 10/29/2018 - 03:33 EndoGastric Solutions Announces Data Presented at ACG 2018 Provide Additional Validation of the Safety and Clinical Efficacy of TIF 2.0 Procedure for the Treatment of GERD
Tue, 07/10/2018 - 03:10 EndoGastric Solutions Secures $30.5 Million In New Financing
Wed, 05/30/2018 - 23:03 EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients